{"text": ["Achillion", "Completes", "Enrollment", "in", "Rare", "Blood", "Disorder", "Study"], "created_at": "2019-03-28 23:10:33"}
{"text": ["Achillion", "Completes", "Enrollment", "in", "Rare", "Blood", "Disorder", "Study"], "created_at": "2019-03-28 23:10:33"}
{"text": ["Aerie", "(AERI)", "Improves", "22%", "YTD:", "Is", "Momentum", "Likely", "to", "Sustain?"], "created_at": "2019-03-28 23:10:29"}
{"text": ["Aerie", "(AERI)", "Improves", "22%", "YTD:", "Is", "Momentum", "Likely", "to", "Sustain?"], "created_at": "2019-03-28 23:10:29"}
{"text": ["AbbVie's", "big", "acquisition", "blowup:", "A", "one-off", "or", "an", "omen?"], "created_at": "2019-03-28 21:44:58"}
{"text": ["Novartis", "(NVS)", "Receives", "FDA", "Approval", "for", "MS", "Drug", "Mayzent"], "created_at": "2019-03-28 00:07:05"}
{"text": ["Novartis", "(NVS)", "Receives", "FDA", "Approval", "for", "MS", "Drug", "Mayzent"], "created_at": "2019-03-28 00:07:05"}
